Nitric oxide plays an important role in stem cell differentiation and in endothelial cells it is expressed by endothelial nitric oxide synthase (eNOS) which is located within membrane caveolae through scaffolding with caveolin-1 (CAV-1WT) which inhibits NO production. In this study, we modified rat bone marrow mesenchymal stem cells (rBMSCs) with lentiviral vectors to co-express eNOS and mutant caveolin-1 (CAV-1F92A) to enhance NO generation and investigated endothelial reprogramming. A lenti-eNOS-GFP fusion vector which allowed FACS selection of eNOS positive cells increased NO production (6.9 ± 0.8 μM) compared to GFP alone (1.04 ± 0.22 μM) and un-transduced cells (0.91± 0.35 μM) (pb0.05). eNOS-GFP and GFP cells were further re-transduced with CAV-1F92A or CAV-1WT. rBMSCeNOS+ CAV-1F92A showed enhanced in vitro capillary tubule formation, upregulation of endothelial specific CD31, V-cadherin gene expression which was reversed by treatment with the eNOS inhibitor L-NAME. Activity of an endothelial specific FLT1-eGFP lentiviral-reporter was also increased compared to controls. Furthermore, arterial specific Notch1, Hey 1 and DII4 gene expression was increased in rBMSCeNOS+ CAV-1F92A whereas venous specific COUP-TFII and lymphatic specific Prox1 expression was significantly reduced. Canonical Wnt3A gene expression was increased in rBMSCeNOS +CAV-1F92A and treatment with L-NAME, resulted in reduced CD31 and Wnt3A expression, and the Wnt inhibitor Dkk-1 also decreased CD31 expression. Western blot analysis showed increased β-catenin expression in rBMSCeNOS +CAV-1F92A confirming the relationship between NO and Wnt/β-catenin signaling. Furthermore rBMSCeNOS+CAV-1F92A cells showed decreased histone deacytaylase SIRT6 and DNA methyltransferase DNMT1 expression which was reversed with L-NAME treatment highlighting that NO may drive epigenetic modification during reprogramming. Finally, subcutaneous implantation of the rBMSCeNOS +CAV-1F92A cells seeded in polyurethane scaffolds in rats, resulted in formation of blood vessels. In summary, our data suggest that nitric oxide activates Wnt/-β-catenin signaling to promote endothelial reprogramming of BMSCs and may provide a novel platform for vascular repair. The homeodomain transcription factor NKX2-5 is essential for the development and normal physiology of the vertebrate heart. However, despite extensive analyses, the direct downstream effectors of NKX2.5 function during the differentiation of cardiac progenitor cells (CPCs) are largely unknown. We have identified Furin, which is coding for a proprotein convertase, as a direct transcriptional target of NKX2-5 and studied its role during cardiac development.
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Using a genome wide distribution approach we found a region close to the Furin gene enriched for NKX2-5 binding. That region is able to drive LacZ expression in a transgenic mouse assay in a pattern comparable to that of the endogenous Furin. On a Nkx2-5 null mutant background, the expression of the Furin-enhancer-LacZ transgene is upregulated in the heart in a similar way as the endogenous Furin mRNA is in the same mutant embryos. Moreover, heart expression of endogenous Furin is downregulated when that enhancer is deleted in a mutant mouse model. Taken together those results show that we have identified a cardiac enhancer of Furin, directly repressed by NKX2-5.
To assess the function of Furin we specifically deleted its expression in CPCs using a conditional mouse knockout. Cardiomyocyte specific mutant embryos for Furin show a whole series of cardiac abnormalities including ventricular septal defect and a range of defects in the outflow tract formation. Moreover, premature expression of cardiac differentiation markers in the CPCs of the anterior heart field of the mutant embryos suggests a role for Furin in the differentiation of those cells. Twist1 encodes a basic helix-loop-helix domain (bHLH) transcription factor that regulates the differentiation of cranial neural crest and head mesoderm during craniofacial development. To gain insight into the transcriptional network in which TWIST1 operates, we identified TWIST1 interacting proteins in mouse neural crest stem cells and fibroblasts. Using the BioID proteomic approach, we were Abstracts S135
